[Seite 38↓]


(1) Akerman S, Williamson DJ, Kaube H, Goadsby PJ (2002) Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br. J. Pharmacol.; 137: 62-8.

(2) Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J (2001) Calcitonin gene-related peptide levels during nitric oxide-induced headache in patients with chronic tension-type headache. Eur J Neurol.; 8: 173-8.

(3) Bari F, Paprika D, Jancso G, Domoki F (2000) Capsaicin-sensitive mechanisms are involved in cortical spreading depression-associated cerebral blood flow changes in rats. Neurosci Lett.; 292: 17-20.

(4) Bjornsson A, Gudmundsson G, Gudfinnsson E, Hrafnsdottir M, Benedikz J, Skuladottir S, Kristjansson K, Frigge ML, Kong A, Stefansson K, Gulcher JR (2003) Localization of a Gene for Migraine without Aura to Chromosome 4q21. Am J Hum Genet.; 73: 986-93.

(5) Borgland SL (2001) Acute opioid receptor desensitization and tolerance: is there a link? Clin Exp Pharmacol Physiol. 2001; 28: 147-54.

(6) Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM (2001) Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol.; 50: 582-7.

(7) Bradley DP, Smith MI, Netsiri C, Smith JM, Bockhorst KH, Hall LD, Huang CL, Leslie RA, Parsons AA, James MF (2001) Diffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: comparison of sumatriptan and tonabersat. Exp Neurol.; 172: 342-53.

(8) Buzzi MG, Sakas DE, Moskowitz MA (1989) Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater. Eur J Pharmacol ; 165: 251-8.

(9) Buzzi MG, Moskowitz MA (1990) The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol.; 99: 202-6.

(10) Cader ZM, Noble-Topham S, Dyment DA, Cherny SS, Brown JD (2003) Significant linkage to migraine with aura on chromosome 11q24. Hum Mol Genet.; 12: 2511-7.

(11) Centonze V, Bassi A, Causarano V, Dalfino L, Cassiano MA, Centonze A, Fabbri L, Albano O (2000) Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependence and tachyphylaxis. Funct Neurol. 15: 167-70.

[Seite  39↓]

(12) Colasanti M, Suzuki H (2000) The dual personality of NO. Trends Pharmacol Sci.; 21(7): 249-52.

(13) Cutrer FM, Sorensen AG, Weisskoff RM, Ostergaard L, Sanchez del Rio M, Lee EJ, Rosen BR, Moskowitz MA (1989) Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol.; 43: 25-31.

(14) Diener HC (2003) RPR100893 Study Group. RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia.; 23: 183-5.

(15) Diener HC, Limmroth V (1999) Acute management of migraine: triptans and beyond. Curr Opin Neurol.; 12: 261-7.

(16) Diener HC (1999) Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group. Cephalalgia.; 19: 581-8.

(17) Diener HC (2003) Pharmacological approaches to migraine. J Neural Transm Suppl. 2003; 64: 35-63.

(18) Dirnagl U, Niwa K, Lindauer U. Villringer A (1994) Coupling of cerebral blood flow to neuronal activation: role of adenosine and nitric oxide. Am. J. Physiol.; 267: H296-301.

(19) Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC (1991) Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience.; 44: 97-112.

(20) Dimitriadou V, Buzzi MG, Theoharides TC, Moskowitz MA (1992) Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience.; 48: 187-203.

(21) Dreier JP, Korner K, Ebert N, Gorner A, Rubin I, Back T, Lindauer U, Wolf T, Villringer A, Einhaupl KM, Lauritzen M, Dirnagl U (1998) Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab.; 18: 978-90.

(22) Ducros A, Joutel A, Vahedi K, Cecillon M, Ferreira A, Bernard E, Verier A, Echenne B, Lopez de Munain A, Bousser MG, Tournier-Lasserve E (1997) Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol.; 42: 885-90.

[Seite  40↓]

(23) Dunn AK, Bolay H, Moskowitz MA, Boas DA (2001) Dynamic imaging of cerebral blood flow using laser speckle. J Cereb Blood Flow Metab.; 21: 195-201.

(24) Ebersberger A, Schaible HG, Averbeck B, Richter F (2001) Is there a correlation between spreading depression, neurogenic inflammation, and nociception that might cause migraine headache? Ann Neurol.; 49: 7-13.

(25) Edvinsson L, Hara H, Uddman R (1989) Retrograde tracing of nerve fibers to the rat middle cerebral artery with true blue: colocalization with different peptides. J Cereb Blood Flow Metab.; 9: 212-8.

(26) Edvinsson L, Mulder H, Goadsby PJ, Uddman R (1998) Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J Auton Nerv Syst.; 70: 15-22.

(27) Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell.; 87: 543-52.

(28) Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet.; 358: 1668-75.

(29) Fozard JR (1995) The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine? Arch Int Pharmacodyn Ther.; 329: 111-9.

(30) Fozard JR, Kalkman HO (1994) 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Naunyn Schmiedebergs Arch Pharmacol.; 350: 225-9.

(31) Gallai V, Floridi A, Mazzotta G, Codini M, Tognoloni M, Vulcano MR, Sartori M, Russo S, Alberti A, Michele F, Sarchielli P (1996) L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura. Acta Neurol Scand; 94: 151–60.

(32) Gardner K, Barmada MM, Ptacek LJ, Hoffman EP (1997) A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology.; 49: 1231-8.

(33) Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J, Altman J, Goadsby PJ, Macrae A (2003) Premonitory symptoms in migraine: An electronic diary study. Neurology.; 60: 935-40.

(34) Goadsby PJ, Edvinsson L, Ekman R (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol.; 23: 193-6.

[Seite  41↓]

(35) Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol.; 33: 48-56.

(36) Goadsby PJ (1993) Inhibition of calcitonin gene-related peptide by h-CGRP(8-37) antagonizes the cerebral dilator response from nasociliary nerve stimulation in the cat. Neurosci Lett.; 151: 13-6.

(37) Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B, Kwong KK, Cutrer FM, Rosen BR, Tootell RB, Sorensen AG, Moskowitz MA (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A.; 98: 4687-92.

(38) Headache Classification Committee of the International Headache Society (1998) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia.; 8 Suppl 7: 1-96.

(39) Headache Classification Committee of the International Headache Society (2004) The international classification of headache disorders. Cephalalgia.; 24 Suppl 1: 1-150.

(40) Hoskin KL, Bulmer DC, Goadsby PJ (1999) Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. Neurosci. Lett.,14: 173-6.

(41) Jhee SS, Shiovitz T, Crawford AW, Cutler NR (2001); Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review. Clin Pharmacokinet.; 40: 189-205.

(42) Johnson KW, Nelson DL, Dieckman DK, Wainscott DB, Lucaites VL, Audia JE, Owton WM, Phebus LA (2003) Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation. Cephalalgia.; 23: 117-123.

(43) Jones KW, Ehm MG, Pericak-Vance MA, Haines JL, Boyd PR, Peroutka SJ (2001) Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus. Genomics.; 78: 150-4.

(44) Jones MG, Lever I, Bingham S, Read S, McMahon SB, Parson A (2001) Nitric oxide potentiates response of trigeminal neurons to dural or facial stimulation in the rat. Cephalalgia.; 21: 643-55.

(45) Katsarava Z, Diener HC, Limmroth V (2001) Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans. Drug Saf ; 24: 921-7.

(46) Kaube H, Hoskin KL, Goadsby PJ (1993) Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol.; 109: 788-92.

[Seite  42↓]

(47) Kavuk I, Katsarava, Z, Diener H-C, (2003) Epidemiologie von Kopfschmerzen; in Diener H-C Referenzreihe Neurologie: Kopfschmerz: 10-16.

(48) Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, Nagano T (1998) Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem.; 70: 2446-53.

(49) Kunkler PE, Kraig RP (2003) Hippocampal spreading depression bilaterally activates the caudal trigeminal nucleus in rodents. Hippocampus; 13: 835-44.

(50) Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM (2001) The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem Biol.; 8: 759-66.

(51) Lambert GA, Donaldson C, Boers PM, Zagami AS (2000) Activation of trigeminovascular neurons by glyceryl trinitrate. Brain Res.; 887: 203-10.

(52) Lambert GA, Michalicek J, Storer RJ, Zagami AS (1999) Effect of cortical spreading depression on activity of trigeminovascular sensory neurons. Cephalalgia.; 19: 631-8.

(53) Laroux FS, Lefer DJ, Kawachi S, Scalia R, Cockrell AS, Gray L, Van der Heyde H, Hoffman JM, Grisham MB (2000) Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid Redox Signal.; 2: 391-6.

(54) Lassen NA (1968) Brain extracellular pH: the main factor controlling cerebral blood flow. Scand. J.Clin. Lab. Invest.; 22: 247-251.

(55) Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J (1997) Nitric oxide synthase inhibition in migraine. Lancet.; 349: 401-2.

(56) Lashley KS (1941) Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry ; 46: 331-9.

(57) Leao AAP (1944) Spreading depression of activity in the cerebral cortex. J Neurophysiol.; 7: 359-390.

(58) Leao AAP, Morison RS (1945) Propagation of spreading cortical depression. J Neurophysiol ; 8: 33-45.

(59) Lee WS, Moskowitz MA (1993) Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater. Brain Res.; 626: 303-5.

(60) Limmroth V, Katsarava Z, Liedert B, Guehring H, Schmitz K, Diener HC, Michel MC (2001) An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain.; 92: 101-6.

(61) Logothetis NK (2003) The underpinnings of the BOLD functional magnetic resonance imaging signal. Neurosci.; 23: 3963-71.

[Seite  43↓]

(62) MacLennan SJ, Cambridge D, Whiting MV, Marston C, Martin GR (1998) Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine. Eur J Pharmacol.; 361: 191-7.

(63) Markowitz S, Saito K, Moskowitz MA (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci.; 7: 4129-36.

(64) Marrannes R, Willems R, De Prins E, Wauquier A (1988) Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res.; 457: 226-40.

(65) Mayberg M, Langer RS, Zervas NT, Moskowitz MA (1981) Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science.; 213: 228-230.

(66) McMenamin PG (1999) Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations. J Comp Neurol.; 405: 553-62.

(67) Mylecharane EJ (1991) 5-HT2 receptor antagonists and migraine therapy. J Neurol.; 238 Suppl 1: 45-52.

(68) Millner PM (1958) Note on a possible correspondence between the scotomas of migraine and sprerading depession of Leao. Electroencephalograph Clin Neurophysiol.; 10: 705.

(69) Mitsikostas DD, Sanchez del Rio M (2001) Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Res Brain Res Rev.; 35: 20-35.

(70) Moncada S "Ottorino Rossi" Award 1997. The biology of nitric oxide. Funct Neurol.; 12: 134-40.

(71) Moskowitz MA, Nozaki K, Kraig RP (1993) Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci.; 13: 1167-77.

(72) Nyholt DR, Curtain RP, Griffiths LR (2000) Familial typical migraine: significant linkage and localization of a gene to Xq24-28. Hum Genet.; 107: 18-23.

(73) Olesen J, Larsen B, Lauritzen M (1981) Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol.; 9: 344-52.

[Seite  44↓]

(74) Olesen J, Iversen HK, Thomsen LL (1993) Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport.; 4: 1027-30.

(75) Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell.; 87: 543-52.

(76) Papagallo M, Szabo Z, Esposito G (1999) maging Neurogenic Inflammation in Patients with Migraine Headaches. Neurology.; 52: A274-A275.

(77) Pardutz A, Krizbai I, Multon S, Vecsei L, Schoenen J (2000) Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport.; 11: 3071-5.

(78) O.B. Paulson and E.A. Newman (1987) Does the release of potassium from astrocyte endfeet regulate cerebral blood flow. Science.; 237, 896-898.

(79) Piper RD, Edvinsson L, Ekman R, Lambert GA (1993) Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine. Cephalalgia.; 13: 180-3.

(80) Pittler MH, Vogler BK, Ernst E (2000) Feverfew for preventing migraine. Cochrane Database Syst Rev.; 3: CD002286.

(81) Rasmussen BK, Olesen J (1992) Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia.; 12: 221-8.

(82) Ray BS, Wolff HG (1940) Experimental studies and headache. Pain sensitive structures of the head and their significance in headache. Arch Surg.; 41: 813-857.

(83) Rebeck GW, Maynard KI, Hyman BT, Moskowitz MA (1994) Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Proc Natl Acad Sci U S A.; 91: 3666-9.

(84) Reuter U, Sanchez del Rio M, Moskowitz MA (2000) Experimental models of migraine. Funct Neurol.; 15 Suppl 3: 9-18.

(85) Russell MB, Iversen HK, Olesen J (1994) Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia.; 14: 107-17.

(86) Sarchielli P, Tognoloni M, Russo S, Vulcano MR, Feleppa M, Mala M, Sartori M, Gallai (1996) Variations in the platelet arginine/nitric oxide pathway during the ovarian cycle in females affected by menstrual migraine. Cephalalgia.; 16: 468–75.

[Seite  45↓]

(87) Schmuck K, Ullmer C, Kalkman HO, Probst A, Lubbert H (1996) Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache? Eur J Neurosci.; 8: 959-67.

(88) Shimomura T, Murakami F, Kotani K, Ikawa S, Kono S (1999) Platelet nitric oxide metabolites in migraine. Cephalalgia.; 19: 218–22.

(89) Somjen GG (2001) Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev.; 81: 1065-96.

(90) Stepien A, Chalimoniuk M Stepien A, Chalimoniuk M (1998) Level of nitric oxide-dependent cGMP in patients with migraine. Cephalalgia.; 18: 631–4.

(91) Strecker T, Dux M, Messlinger K (2002) Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow. J Vasc Res.; 39: 489-96.

(92) Suzuki N, Hardebo JE, Kahrstrom J, Owman C (1990) Effect on cortical blood flow of electrical stimulation of trigeminal cerebrovascular nerve fibres in the rat. Acta Physiol Scand.; 138: 307-16.

(93) Suzuki N, Hardebo JE, Kahrstrom J, Owman C (1990) Selective electrical stimulation of postganglionic cerebrovascular parasympathetic nerve fibers originating from the sphenopalatine ganglion enhances cortical blood flow in the rat. J Cereb Blood Flow Metab.; 10: 383-91.

(94) Tassorelli C, Joseph SA (1995) Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. Brain Res.; 682: 167-81.

(95) The Diclofenac-K/Sumatriptan Migraine Study Group (1999) Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. Cephalalgia.; 19: 232-40.

(96) The Subcutaneous Sumatriptan International Study Group (1991) Treatment of migraine attacks with sumatriptan. N Engl J Med.; 325: 316-21.

(97) Theoharides TC (1996) The mast cell: a neuroimmunoendocrine master player. Int J Tissue React.; 18: 1-21.

(98) Trainor DC, Jones RC (1966) Headaches in explosive magazine workers. Arch Environ Health.; 12: 231–4.

(99) Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J (1985) Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett.; 62: 131-6.

[Seite  46↓]

(100) Uhl GR, Walther D, Nishimori T, Buzzi MG, Moskowitz MA (1991) Jun B, c-jun, jun D and c-fos mRNAs in nucleus caudalis neurons: rapid selective enhancement by afferent stimulation. Brain Res Mol Brain Res.; 11: 133-41.

(101) Waeber C, Moskowitz MA (1998) 5-Hydroxytryptamine1A and 5-hydroxytryptamine1B receptors stimulate [35S]guanosine-5'-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography. Mol Pharmacol.; 52: 623-31.

(102) Waeber C, Moskowitz MA (2003) Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology.; 61: S9-S20.

(103) Wessman M, Kallela M, Kaunisto MA, Marttila P, Sobel E, Hartiala J, Oswell G, Leal SM, Papp JC, Hamalainen E, Broas, P, Joslyn G, Hovatta I, Hiekkalinna T, Kaprio J, Ott J, Cantor RM, Zwart JA, Ilmavirta M, Havanka H, Farkkila M, Peltonen L, Palotie A (2002) A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet.; 70: 652-62.

(104) Williamson DJ, Hargreaves RJ (2001) Neurogenic inflammation in the context of migraine. Microsc Res Tech.; 53: 167-78

(105) Woods RP, Iacoboni M, Mazziotta JC (1994) Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med.; 331: 1689-92.

(106) Wolf T, Lindauer U, Villringer A, Dirnagl U (1997) Excessive oxygen or glucose supply does not alter the blood flow response to somatosensory stimulation or spreading depression in rats. Brain Res.; 761: 290-9.

(107) Wolff HG (1963) Headache and other head pain. New York: Oxford University Press.

[Seite 47↓]

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: